Search Results 1721-1730 of 21425 for anti-TNF drugs

  1. Nonmelanoma Skin Cancer Clinical Trials - Mayo Clinic Research

    Open-label study using ASP-1929 photoimmunotherapy in combination with anti-PD1 therapy in patients with recurrent or metastatic head and neck and squamous cell ...

  2. Work Rehabilitation Center in Rochester, Minnesota - Work injury treatment programs - Mayo Clinic

    Work injury treatment programs emphasize body performance, biomechanics and functional activities of everyday living. Each person receives a unique medical ...

  3. Tenofovir (Oral Route) Proper Use - Mayo Clinic

    For oral dosage forms (oral powder or tablets):. For treatment of HIV infection: Adults and children 2 years of age and older and weighs 35 kilograms (kg) or ...

  4. Human Papillomavirus Vaccine (Intramuscular Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  5. Sulfur Hexafluoride Lipid Type A Microspheres (Injection Route, Intravenous Route) Description and Brand Names - Mayo Clinic

    Ultrasound contrast agents are used to help provide a clear picture during ultrasound. Ultrasound is a special kind of diagnostic procedure. It uses high- ...

  6. Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer - Mayo Clinic

    - Anti-cancer treatment (chemotherapy, radiotherapy, or other investigational therapy) within 4 weeks prior to entering the study (6 weeks prior to study ...

  7. Prednisone (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  8. Ayalew Tefferi, M.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher Ayalew Tefferi, M.D., studies the pathophysiology, natural history and treatment of chronic myeloproliferative neoplasms (MPN).

  9. A Phase 2/3 Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab in Subjects With Unresectable or Metastatic Melanoma - Mayo Clinic

    ... treatment for unresectable or metastatic melanoma (except BRAF directed therapy). Has received prior therapy with an anti-PD-1, anti-PD-L1, anti-PD-L2, anti ...

  10. Fructose, Dextrose, And Phosphoric Acid (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...